We are live on ! Find out more
RCM

Radcliffe Capital Management Portfolio holdings

AUM $1.33B
1-Year Est. Return 1.18%
This Fund
S&P 500
This Quarter Est. Return
-1.02%
1 Year Est. Return
+1.18%
3 Year Est. Return
+4.94%
5 Year Est. Return
-24.37%
10 Year Est. Return
-27.33%
AUM
$3.82B
AUM Growth
+$383M
Cap. Flow
-$303M
Cap. Flow %
-7.94%
Top 10 Hldgs %
17.8%
Holding
1,178
New
280
Increased
3
Reduced
68
Closed
128
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
APGNW
951
DELISTED
Apexigen, Inc. WarrantApexigen, Inc. Warrant
APGNW
$537K 0.01%
53,688
TINV.WS
952
DELISTED
Tiga Acquisition Corp. Warrants, each warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share
TINV.WS
$532K 0.01%
52,528
PSQH.WS icon
953
PSQ Holdings, Inc. Warrants, Each whole warrant exercisable for 1/15th of a share of Class A common stock at an exercise price of $172.50 per share
PSQH.WS
$1.73M
$529K 0.01%
54,879
MMVWW
954
DELISTED
MultiMetaVerse Holdings Limited Warrant
MMVWW
$500K 0.01%
50,000
-25,000
-33% -$15.8K
RONI.WS
955
DELISTED
Rice Acquisition Corp. II Redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
RONI.WS
$500K 0.01%
50,000
LVACW
956
DELISTED
LAVA Medtech Acquisition Corp. Warrants
LVACW
$500K 0.01%
+50,000
New +$25.7K
REVEW
957
DELISTED
Alpine Acquisition Corp Warrant
REVEW
$500K 0.01%
+50,000
New +$25K
OABIW icon
958
OmniAb Inc Warrant
OABIW
$9.04M
$498K 0.01%
+49,862
New +$31.2K
SHCA
959
DELISTED
Spindletop Health Acquisition Corp. Class A Common Stock
SHCA
$498K 0.01%
+50,000
New +$478K
FRLAW
960
DELISTED
Fortune Rise Acquisition Corporation Warrant
FRLAW
$497K 0.01%
+50,000
New +$20.4K
ESLAW icon
961
Estrella Immunopharma Warrant
ESLAW
$138K
$496K 0.01%
50,000
RCHGW
962
DELISTED
Recharge Acquisition Corp. Warrant
RCHGW
$495K 0.01%
50,000
SPAQ.WS
963
DELISTED
Spartan Acquisition Corp. III Warrants, exercisable for one share of Class A Common Stock
SPAQ.WS
$494K 0.01%
50,000
-25,000
-33% -$32.7K
TRAQ.WS
964
DELISTED
Trine II Acquisition Corp. Redeemable Warrants, each whole warrant exercisable for one Class A Ordinary Share at an exercise price of $11.50 per share
TRAQ.WS
$493K 0.01%
+50,000
New +$28.3K
FRONW
965
DELISTED
Frontier Acquisition Corp. Warrant
FRONW
$488K 0.01%
50,000
FVIV.WS
966
DELISTED
Fortress Value Acquisition Corp. IV Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 per share
FVIV.WS
$488K 0.01%
50,000
FMIVW
967
DELISTED
Forum Merger IV Corporation Warrant
FMIVW
$487K 0.01%
49,999
PKBOW
968
DELISTED
Peak Bio, Inc. Warrant
PKBOW
$487K 0.01%
50,000
FLYX icon
969
flyExclusive
FLYX
$62.1M
$486K 0.01%
50,000
GLHAW
970
DELISTED
Glass Houses Acquisition Corp. Warrant
GLHAW
$486K 0.01%
50,000
TRTL
971
DELISTED
TortoiseEcofin Acquisition Corp. III
TRTL
$485K 0.01%
50,000
MTAL
972
DELISTED
Metals Acquisition
MTAL
$483K 0.01%
+50,000
New +$486K
ATA.WS
973
DELISTED
Americas Technology Acquisition Corp.Redeemable Warrants, each whole warrant exercisable for one Ordinary Share at an exercise price of $11.50
ATA.WS
$481K 0.01%
47,500
FRSGW
974
DELISTED
First Reserve Sustainable Growth Corp. Warrant
FRSGW
$464K 0.01%
46,910
-53,089
-53% -$55.5K
CIIG
975
DELISTED
CIIG Capital Partners II, Inc. Class A Common Stock
CIIG
$462K 0.01%
+46,763
New +$461K

Similar funds

Radcliffe Capital Management's Q4 2021 Portfolio in Review

As of Q4 2021, Radcliffe Capital Management held 1,178 positions worth $3.82B, up 11% from $3.44B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Radcliffe Capital Management withdrew a net $303M in Q4 2021, closing 128 positions and reducing 68 holdings. Its most notable exit was Sierra Lake Acquisition Corp. Unit, an estimated $27.9M position sold in full.

By sector, the portfolio is most concentrated in Financials at 40% of assets, up from 34% a quarter earlier, followed by Healthcare and Technology.

Against the trend, Radcliffe Capital Management opened a new position in Enphys Acquisition Corp. worth $23.8M.

  • Radcliffe Capital Management's largest Q4 2021 buy was Enphys Acquisition Corp.: 2,469,892 shares worth $23.8M.
  • Radcliffe Capital Management added most to Horizon Acquisition Corporation II in Q4 2021, an estimated $2.46M increase.
  • Radcliffe Capital Management's biggest Q4 2021 reduction was USHG Acquisition Corp., cutting an estimated $2.74M.
  • Radcliffe Capital Management fully exited Sierra Lake Acquisition Corp. Unit in Q4 2021, selling an estimated $27.9M.
  • Radcliffe Capital Management's ten largest holdings make up 18% of its $3.82B portfolio in Q4 2021.
  • Radcliffe Capital Management opened 280 new positions and closed 128 in Q4 2021.
  • Radcliffe Capital Management's portfolio value rose 11% quarter-over-quarter to $3.82B.

Based on Radcliffe Capital Management's 13F filing for Q4 2021, filed 14 Feb 2022.